11-34113802-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_024662.3(NAT10):c.459C>T(p.Thr153=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00314 in 1,614,024 control chromosomes in the GnomAD database, including 106 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.017 ( 50 hom., cov: 31)
Exomes 𝑓: 0.0017 ( 56 hom. )
Consequence
NAT10
NM_024662.3 synonymous
NM_024662.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.153
Genes affected
NAT10 (HGNC:29830): (N-acetyltransferase 10) The protein encoded by this gene is an RNA cytidine acetyltransferase involved in histone acetylation, tRNA acetylation, the biosynthesis of 18S rRNA, and the enhancement of nuclear architecture and chromatin organization. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 11-34113802-C-T is Benign according to our data. Variant chr11-34113802-C-T is described in ClinVar as [Benign]. Clinvar id is 791314.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.153 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0567 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAT10 | NM_024662.3 | c.459C>T | p.Thr153= | synonymous_variant | 5/29 | ENST00000257829.8 | NP_078938.3 | |
NAT10 | NM_001144030.2 | c.243C>T | p.Thr81= | synonymous_variant | 3/27 | NP_001137502.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAT10 | ENST00000257829.8 | c.459C>T | p.Thr153= | synonymous_variant | 5/29 | 1 | NM_024662.3 | ENSP00000257829 | P1 | |
NAT10 | ENST00000531159.6 | c.243C>T | p.Thr81= | synonymous_variant | 3/27 | 2 | ENSP00000433011 | |||
NAT10 | ENST00000527971.5 | c.459C>T | p.Thr153= | synonymous_variant | 4/8 | 2 | ENSP00000437324 | |||
NAT10 | ENST00000529523.5 | downstream_gene_variant | 4 | ENSP00000435569 |
Frequencies
GnomAD3 genomes AF: 0.0168 AC: 2548AN: 152110Hom.: 48 Cov.: 31
GnomAD3 genomes
AF:
AC:
2548
AN:
152110
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00443 AC: 1113AN: 251428Hom.: 28 AF XY: 0.00330 AC XY: 448AN XY: 135882
GnomAD3 exomes
AF:
AC:
1113
AN:
251428
Hom.:
AF XY:
AC XY:
448
AN XY:
135882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00172 AC: 2507AN: 1461796Hom.: 56 Cov.: 34 AF XY: 0.00150 AC XY: 1090AN XY: 727208
GnomAD4 exome
AF:
AC:
2507
AN:
1461796
Hom.:
Cov.:
34
AF XY:
AC XY:
1090
AN XY:
727208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0169 AC: 2566AN: 152228Hom.: 50 Cov.: 31 AF XY: 0.0163 AC XY: 1211AN XY: 74432
GnomAD4 genome
AF:
AC:
2566
AN:
152228
Hom.:
Cov.:
31
AF XY:
AC XY:
1211
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at